DUO Venous Stent System
Device Deep Venous Disease
General payments
$110,852
Research payments
$1,542,928
Through program year 2023, $110,852 in general payments and $1,542,928 in research payments were reported against DUO Venous Stent System (Deep Venous Disease).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $30,000 | 11 |
| 2023 | Research | $281,207 | 61 |
| 2022 | General | $31,052 | 17 |
| 2022 | Research | $634,917 | 117 |
| 2021 | General | $49,799 | 62 |
| 2021 | Research | $626,805 | 96 |
Breakdown
Each share is of general payments naming this product in 2023.
Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2023 where a state was reported.
Records
90 general · 274 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.